The North American collaborative study of maternal phenylketonuria (PKU)

R. Koch, H. L. Levy, Reuben Matalon, B. Rouse, W. Hanley, E. G. Friedman, C. Azen, F. De la Cruz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Nationwide neonatal screening for phenylketonuria (PKU) has created an unexpected problem as these women are reaching childbearing age. Surveys have revealed that maternal phenylalanine blood concentrations >1200 μmol/L (≥20 mg/dL) are associated with microcephaly, mental retardation, congenital heart defects, and intrauterine growth retardation among offspring. It is estimated that as many as 3000 hyperphenylalaninemic (HPA) women may be at risk for producing these fetal abnormalities. To examine this problem, the North American maternal PKU Collaborative Study (MPKUCS) has been developed. The Study has been designed to evaluate the efficacy of a phenylalanine-restricted diet in reducing the fetal morbidity associated with maternal HPA. Preliminary findings indicate that phenylalanine restriction should begin before conception for women with PKU planning a pregnancy. Dietary control should maintain average maternal blood phenylalanine levels at 360 μmol/L (6 mg/dL) and should provide adequate calorie, protein, vitamin and mineral intake. Pregnant HPA women who achieved metabolic control after conception but by the tenth week of pregnancy had a better offspring outcome than anticipated.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalInternational Pediatrics
Volume8
Issue number1
StatePublished - 1993
Externally publishedYes

Fingerprint

Maternal Phenylketonuria
Phenylalanine
Phenylketonurias
Mothers
Reducing Diet
Neonatal Screening
Pregnancy
Microcephaly
Fetal Growth Retardation
Congenital Heart Defects
Vitamins
Intellectual Disability
Minerals
Pregnant Women
Morbidity
Proteins

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Koch, R., Levy, H. L., Matalon, R., Rouse, B., Hanley, W., Friedman, E. G., ... De la Cruz, F. (1993). The North American collaborative study of maternal phenylketonuria (PKU). International Pediatrics, 8(1), 89-96.

The North American collaborative study of maternal phenylketonuria (PKU). / Koch, R.; Levy, H. L.; Matalon, Reuben; Rouse, B.; Hanley, W.; Friedman, E. G.; Azen, C.; De la Cruz, F.

In: International Pediatrics, Vol. 8, No. 1, 1993, p. 89-96.

Research output: Contribution to journalArticle

Koch, R, Levy, HL, Matalon, R, Rouse, B, Hanley, W, Friedman, EG, Azen, C & De la Cruz, F 1993, 'The North American collaborative study of maternal phenylketonuria (PKU)', International Pediatrics, vol. 8, no. 1, pp. 89-96.
Koch R, Levy HL, Matalon R, Rouse B, Hanley W, Friedman EG et al. The North American collaborative study of maternal phenylketonuria (PKU). International Pediatrics. 1993;8(1):89-96.
Koch, R. ; Levy, H. L. ; Matalon, Reuben ; Rouse, B. ; Hanley, W. ; Friedman, E. G. ; Azen, C. ; De la Cruz, F. / The North American collaborative study of maternal phenylketonuria (PKU). In: International Pediatrics. 1993 ; Vol. 8, No. 1. pp. 89-96.
@article{6c789ab383254f27b14727a93d317eec,
title = "The North American collaborative study of maternal phenylketonuria (PKU)",
abstract = "Nationwide neonatal screening for phenylketonuria (PKU) has created an unexpected problem as these women are reaching childbearing age. Surveys have revealed that maternal phenylalanine blood concentrations >1200 μmol/L (≥20 mg/dL) are associated with microcephaly, mental retardation, congenital heart defects, and intrauterine growth retardation among offspring. It is estimated that as many as 3000 hyperphenylalaninemic (HPA) women may be at risk for producing these fetal abnormalities. To examine this problem, the North American maternal PKU Collaborative Study (MPKUCS) has been developed. The Study has been designed to evaluate the efficacy of a phenylalanine-restricted diet in reducing the fetal morbidity associated with maternal HPA. Preliminary findings indicate that phenylalanine restriction should begin before conception for women with PKU planning a pregnancy. Dietary control should maintain average maternal blood phenylalanine levels at 360 μmol/L (6 mg/dL) and should provide adequate calorie, protein, vitamin and mineral intake. Pregnant HPA women who achieved metabolic control after conception but by the tenth week of pregnancy had a better offspring outcome than anticipated.",
author = "R. Koch and Levy, {H. L.} and Reuben Matalon and B. Rouse and W. Hanley and Friedman, {E. G.} and C. Azen and {De la Cruz}, F.",
year = "1993",
language = "English (US)",
volume = "8",
pages = "89--96",
journal = "International Pediatrics",
issn = "0885-6265",
publisher = "Miami Children's Hospital Medical Journal Inc.",
number = "1",

}

TY - JOUR

T1 - The North American collaborative study of maternal phenylketonuria (PKU)

AU - Koch, R.

AU - Levy, H. L.

AU - Matalon, Reuben

AU - Rouse, B.

AU - Hanley, W.

AU - Friedman, E. G.

AU - Azen, C.

AU - De la Cruz, F.

PY - 1993

Y1 - 1993

N2 - Nationwide neonatal screening for phenylketonuria (PKU) has created an unexpected problem as these women are reaching childbearing age. Surveys have revealed that maternal phenylalanine blood concentrations >1200 μmol/L (≥20 mg/dL) are associated with microcephaly, mental retardation, congenital heart defects, and intrauterine growth retardation among offspring. It is estimated that as many as 3000 hyperphenylalaninemic (HPA) women may be at risk for producing these fetal abnormalities. To examine this problem, the North American maternal PKU Collaborative Study (MPKUCS) has been developed. The Study has been designed to evaluate the efficacy of a phenylalanine-restricted diet in reducing the fetal morbidity associated with maternal HPA. Preliminary findings indicate that phenylalanine restriction should begin before conception for women with PKU planning a pregnancy. Dietary control should maintain average maternal blood phenylalanine levels at 360 μmol/L (6 mg/dL) and should provide adequate calorie, protein, vitamin and mineral intake. Pregnant HPA women who achieved metabolic control after conception but by the tenth week of pregnancy had a better offspring outcome than anticipated.

AB - Nationwide neonatal screening for phenylketonuria (PKU) has created an unexpected problem as these women are reaching childbearing age. Surveys have revealed that maternal phenylalanine blood concentrations >1200 μmol/L (≥20 mg/dL) are associated with microcephaly, mental retardation, congenital heart defects, and intrauterine growth retardation among offspring. It is estimated that as many as 3000 hyperphenylalaninemic (HPA) women may be at risk for producing these fetal abnormalities. To examine this problem, the North American maternal PKU Collaborative Study (MPKUCS) has been developed. The Study has been designed to evaluate the efficacy of a phenylalanine-restricted diet in reducing the fetal morbidity associated with maternal HPA. Preliminary findings indicate that phenylalanine restriction should begin before conception for women with PKU planning a pregnancy. Dietary control should maintain average maternal blood phenylalanine levels at 360 μmol/L (6 mg/dL) and should provide adequate calorie, protein, vitamin and mineral intake. Pregnant HPA women who achieved metabolic control after conception but by the tenth week of pregnancy had a better offspring outcome than anticipated.

UR - http://www.scopus.com/inward/record.url?scp=0027263887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027263887&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027263887

VL - 8

SP - 89

EP - 96

JO - International Pediatrics

JF - International Pediatrics

SN - 0885-6265

IS - 1

ER -